PMID- 29046394 OWN - NLM STAT- MEDLINE DCOM- 20171129 LR - 20171217 IS - 1470-8728 (Electronic) IS - 0264-6021 (Linking) VI - 474 IP - 23 DP - 2017 Nov 16 TI - Recombinant human islet amyloid polypeptide forms shorter fibrils and mediates beta-cell apoptosis via generation of oxidative stress. PG - 3915-3934 LID - 10.1042/BCJ20170323 [doi] AB - Protein misfolding and aggregation play an important role in many human diseases including Alzheimer's, Parkinson's and type 2 diabetes mellitus (T2DM). The human islet amyloid polypeptide (hIAPP) forms amyloid plaques in the pancreas of T2DM subjects (>95%) that are involved in deteriorating islet function and in mediating beta-cell apoptosis. However, the detailed mechanism of action, structure and nature of toxic hIAPP species responsible for this effect remains elusive to date mainly due to the high cost associated with the chemical synthesis of pure peptide required for these studies. In the present work, we attempted to obtain structural and mechanistic insights into the hIAPP aggregation process using recombinant hIAPP (rhIAPP) isolated from Escherichia coli Results from biophysical and structural studies indicate that the rhIAPP self-assembled into highly pure, beta-sheet-rich amyloid fibrils with uniform morphology. rhIAPP-mediated apoptosis in INS-1E cells was associated with increased oxidative stress and changes in mitochondrial membrane potential. The transcript levels of apoptotic genes - Caspase-3 and Bax were found to be up-regulated, while the levels of the anti-apoptotic gene - Bcl2 were down-regulated in rhIAPP-treated cells. Additionally, the expression levels of genes involved in combating oxidative stress namely Catalase, SOD1 and GPx were down-regulated. rhIAPP exposure also affected glucose-stimulated insulin secretion from isolated pancreatic islets. The aggregation of rhIAPP also occurred significantly faster when compared with that of the chemically synthesized peptide. We also show that the rhIAPP fibrils were shorter and more cytotoxic. In summary, our study is one among the few to provide comprehensive evaluation of structural, biophysical and cytotoxic properties of rhIAPP. CI - (c) 2017 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society. FAU - Dubey, Richa AU - Dubey R AD - Department of Biosciences and Bioengineering, Indian Institute of Technology, Mumbai 400076, India. FAU - Minj, Pooja AU - Minj P AD - Department of Biotechnology, Savitribai Phule Pune University (Formerly University of Pune), Ganeshkhind, Pune, Maharashtra 411007, India. FAU - Malik, Nikita AU - Malik N AD - Department of Biosciences and Bioengineering, Indian Institute of Technology, Mumbai 400076, India. FAU - Sardesai, Devika M AU - Sardesai DM AD - Department of Biotechnology, Savitribai Phule Pune University (Formerly University of Pune), Ganeshkhind, Pune, Maharashtra 411007, India. FAU - Kulkarni, Shruti H AU - Kulkarni SH AD - Department of Biotechnology, Savitribai Phule Pune University (Formerly University of Pune), Ganeshkhind, Pune, Maharashtra 411007, India. FAU - Acharya, Jhankar D AU - Acharya JD AD - Department of Zoology, Savitribai Phule Pune University (Formerly University of Pune), Ganeshkhind, Pune, Maharashtra 411007, India. FAU - Bhavesh, Neel Sarovar AU - Bhavesh NS AD - Transcription Regulation Group, International Centre for Genetic Engineering and Biotechnology, New Delhi 110067, India. FAU - Sharma, Shilpy AU - Sharma S AD - Department of Biotechnology, Savitribai Phule Pune University (Formerly University of Pune), Ganeshkhind, Pune, Maharashtra 411007, India shilpy.sharma@gmail.com ashutoshk@iitb.ac.in. FAU - Kumar, Ashutosh AU - Kumar A AD - Department of Biosciences and Bioengineering, Indian Institute of Technology, Mumbai 400076, India shilpy.sharma@gmail.com ashutoshk@iitb.ac.in. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20171116 PL - England TA - Biochem J JT - The Biochemical journal JID - 2984726R RN - 0 (BCL2 protein, human) RN - 0 (Islet Amyloid Polypeptide) RN - 0 (Proto-Oncogene Proteins c-bcl-2) RN - 0 (Recombinant Proteins) RN - 0 (SOD1 protein, human) RN - 0 (bcl-2-Associated X Protein) RN - EC 1.11.1.6 (Catalase) RN - EC 1.15.1.1 (Superoxide Dismutase-1) RN - EC 3.4.22.- (CASP3 protein, human) RN - EC 3.4.22.- (Caspase 3) SB - IM MH - Apoptosis/*drug effects MH - Caspase 3/biosynthesis MH - Catalase/biosynthesis MH - Cell Line MH - Gene Expression Regulation/drug effects MH - Humans MH - Insulin-Secreting Cells/*metabolism/pathology MH - *Islet Amyloid Polypeptide/chemistry/pharmacology MH - Oxidative Stress/*drug effects MH - Proto-Oncogene Proteins c-bcl-2/biosynthesis MH - Recombinant Proteins/chemistry/pharmacology MH - Superoxide Dismutase-1/biosynthesis MH - bcl-2-Associated X Protein/biosynthesis OTO - NOTNLM OT - amyloid OT - apoptosis OT - human islet amyloid polypeptide OT - solid-state NMR OT - type 2 diabetes EDAT- 2017/10/20 06:00 MHDA- 2017/12/01 06:00 CRDT- 2017/10/20 06:00 PHST- 2017/04/29 00:00 [received] PHST- 2017/10/09 00:00 [revised] PHST- 2017/10/11 00:00 [accepted] PHST- 2017/10/20 06:00 [pubmed] PHST- 2017/12/01 06:00 [medline] PHST- 2017/10/20 06:00 [entrez] AID - BCJ20170323 [pii] AID - 10.1042/BCJ20170323 [doi] PST - epublish SO - Biochem J. 2017 Nov 16;474(23):3915-3934. doi: 10.1042/BCJ20170323.